Navigation Links
Schering-Plough Reports Financial Results for Third Quarter of 2008
Date:10/21/2008

nded September 30,

2007 were mark-to-market gains of $314 million and $282 million,

respectively, related to Euro-denominated currency options related to the

acquisition of OBS.

5/ Special and acquisition-related charges relate to the Productivity

Transformation Program (PTP) which also incorporates the ongoing

integration of OBS. For the three and nine months ended September 30, 2008

these charges were $101 million ($93 million for severance costs and $8

million for integration-related costs) and $218 million, respectively.

Special and acquisition-related charges for the three and nine months

ended September 30, 2007 were $20 million and $32 million, respectively.

6/ Equity income for the three and nine months ended September 30, 2008

include $19 million and $83 million, respectively, of income related to

the termination of a respiratory joint venture with Merck.

SCHERING-PLOUGH CORPORATION

Reconciliation from Reported Net Income Available to Common Shareholders and Reported Diluted Earnings Per Common Share to As Reconciled Amounts for Net Income

Available to Common Shareholders and Diluted Earnings per Common Share

(Amounts in Millions, except per share figures)

To supplement its consolidated financial statements presented in accordance with accounting principles generally accepted in the United States of America (U.S. GAAP), Schering-Plough is providing the supplemental financial information below and on the following pages to reflect "As Reconciled" amounts related to Net income available to common shareholders and Diluted earnings per common share. "As Reconciled" amounts exclude the effects of purchase accounting adjustments, special and acquisition-related items and other specified items.

"As Reconciled" amounts related to Net income available to common shareholders and Diluted earnings per common share are non-U.S. GAAP measures used by
'/>"/>

SOURCE Schering-Plough Corporation
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25

Related medicine news :

1. Schering-Plough Announces Transition of Animal Health Leadership
2. Schering-Plough and Merck Announce Withdrawal of Loratadine/Montelukast NDA and Termination of Respiratory Joint Venture
3. Hagens Berman Appointed Co-Lead Counsel in Case Against Schering-Plough and Merck
4. Emerging Combination Therapies, Including Drugs from Novartis/Schering-Plough and GlaxoSmithKline/Theravance Will Drive the COPD Drug Market to More Than $11 Billion in 2017
5. Bayer/Schering-Plough/Shionogis Avelox Has Advantages Over Levofloxacin in the Treatment of Community-Acquired Pneumonia
6. Schering-Plough Announces Expanded Stock Retention Guidelines for Senior Management
7. Schering-Plough to Webcast Presentation by CEO Fred Hassan at Lehman Brothers Eleventh Annual Global Healthcare Conference
8. Schering-Plough Promotes Ian Mcinnes to President of Global Supply Chain
9. CORRECTED: Hagens Berman Sobol Shapiro Files Suit Against Merck and Schering-Plough
10. Lawsuit Filed in Florida Federal Court Over Marketing of Vytorin and Zetia By Merck and Schering-Plough
11. Schering-Plough CEO to Buy $2 Million in Common Shares
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/24/2014)... in managing patients before, during and after colorectal surgery ... rates, according to researchers who led a study of ... called enhanced recovery, is easier on patients before surgery, ... that are typically prescribed. After surgery, patients are encouraged ... leading to faster recoveries. , Among findings published in ...
(Date:4/24/2014)... professor in the new Institute for Biomedical Sciences ... $2.83 million federal grant to develop novel therapeutics ... grant from the Eunice Kennedy Shriver National Institute ... National Institutes of Health will support Plemper,s drug ... at least one distinct alternative compound. , Infections ...
(Date:4/24/2014)... terminology, and the relevance of palliation in advanced ... randomized controlled trials (RCTs). This is the result ... Quality and Efficiency in Health Care (IQWiG), which ... Together with external experts, IQWiG analysed studies on ... malignant melanoma, and pancreatic cancer. For this purpose, ...
(Date:4/24/2014)... of three survivors of critical illness, according to ... Respiratory Medicine , and the majority of patients ... It is one of the largest studies to ... critical care survivors, according to lead author James ... highlights a significant public health issue, with roughly ...
(Date:4/24/2014)... A Finnish team of researchers was the first in ... which is a tumour of the jaw. , Ameloblastoma ... recur after treatment. Ameloblastoma is most often found in ... by surgery, often resulting in tissue deficiencies in the ... suitable drug therapy could reduce the need for surgery ...
Breaking Medicine News(10 mins):Health News:New approach for surgery patients cuts hospital stays and costs 2Health News:New approach for surgery patients cuts hospital stays and costs 3Health News:Palliation is rarely a topic in studies on advanced cancer 2Health News:Palliation is rarely a topic in studies on advanced cancer 3Health News:Vanderbilt study finds physical signs of depression common among ICU survivors 2Health News:Vanderbilt study finds physical signs of depression common among ICU survivors 3
... to common viruses in daycare puts children with a ... for serious respiratory infections, according to a study from ... of Pediatrics . The researchers say ... born patients, regardless of age, for signs of lung ...
... HealthDay Reporter , FRIDAY, Sept. 24 (HealthDay News) ... the planet, and the second leading cause of death in ... cancer, according to an assessment of cancer trends produced by ... Centers for Disease Control and Prevention, the American Cancer Society ...
... that people choosing to live near to outdoor recreation amenities ... to an increase in all that healthy outdoor activity right ... looking at the relationship between reasons for choosing a neighbourhood ... not the case. In fact researchers found that ...
... begin almost as soon as patients arrive at hospital ... Academic Emergency Medicine , Massachusetts General Hospital (MGH) researchers ... pain were less likely than white patients to be ... significant differences in symptoms. Such practices directly violate ...
... The Nobel Prize, the correlation between genes and lifestyle, and ... of the topics that will be discussed at an international ... in Washington DC. The symposium has been arranged by Karolinska ... National Institutes of Health (NIH), and the Swedish embassy in ...
... MD, chair of the Department of Pediatrics at the ... Physician-in-Chief at Rady Children,s Hospital-San Diego has received a ... Heart, Lung and Blood Institute. A world renowned ... collaborative team of investigators from UC San Diego and ...
Cached Medicine News:Health News:Daycare puts children with lung disease at risk for serious illness 2Health News:As Science Unlocks Secrets, Cancer Rates Fall 2Health News:As Science Unlocks Secrets, Cancer Rates Fall 3Health News:As Science Unlocks Secrets, Cancer Rates Fall 4Health News:Moving closer to outdoor recreation not a recipe for being more physically active 2Health News:Disparities in heart attack treatment may begin in the emergency room 2Health News:Disparities in heart attack treatment may begin in the emergency room 3Health News:Symposium in Washington with world-leading scientists 2
(Date:1/15/2014)... , Jan. 15, 2014  Zafgen, Inc., a leading ... of severely obese patients, today announced initial results ... selective inhibitor of methionine aminopeptidase 2 (MetAP2), in ... of genetic obesity.  These results showed improvements in ...
(Date:1/14/2014)... 14, 2014 The Brandeis Medical Center, led by Dr. ... premier and affordable laser tattoo removal experience with the advanced Astanza ... in providing high quality cosmetic services with cutting edge medical technology ... Southern California has seen a dramatic increase in ...
(Date:1/14/2014)... 14, 2014 NineSigma , Inc., the leading ... Innovation Leadership Summit , May 14-16, 2014 at the ... Ohio . This is the ... to breakthrough achievements through open innovation. Participants will learn ...
Breaking Medicine Technology:Zafgen Announces Initial Results from Phase 2a Study of Beloranib in Patients with Prader-Willi Syndrome 2Zafgen Announces Initial Results from Phase 2a Study of Beloranib in Patients with Prader-Willi Syndrome 3Zafgen Announces Initial Results from Phase 2a Study of Beloranib in Patients with Prader-Willi Syndrome 4Beverly Hills Physician Features Tattoo Removal with the Astanza Duality Laser, Offers $99 Special 2Expect the Unexpected from Leading Global Innovators at NineSigma Leadership Summit, Sharing Winning Strategies to Advance Innovation 2Expect the Unexpected from Leading Global Innovators at NineSigma Leadership Summit, Sharing Winning Strategies to Advance Innovation 3Expect the Unexpected from Leading Global Innovators at NineSigma Leadership Summit, Sharing Winning Strategies to Advance Innovation 4
... , FORT LAUDERDALE, Fla., Dec. 22 LifeSync ... purchased the Besson Patent Portfolio and other wireless vital ... the use of wireless, two-way, digital communication between patient-electrodes ... patient. The acquired patent portfolio includes additional wireless improvements ...
... , HULL, England and FT. SASKATCHEWAN, Canada, ... & Nephew plc (LSE: SN; NYSE: SNN ), ... substantially all of the assets of Nucryst Pharmaceuticals Corp. ("Nucryst") ... manufacturing assets from Nucryst,s Fort Saskatchewan, Canada operations and the ...
Cached Medicine Technology:Smith & Nephew Completes Acquisition of the Assets of Nucryst Pharmaceuticals Corp. 2Smith & Nephew Completes Acquisition of the Assets of Nucryst Pharmaceuticals Corp. 3
... offers an economical, ... alternative to existing ... guarantees accurate and ... the time-consuming recalibration ...
... 2000 is an ... for automated 96-/384-well ... With its ability ... any routine liquid ...
... Multidrop 384 offers lower consumption of ... screening applications. The Multidrop 384 is ... screening and microvolume dispensing into 384- ... outstanding flexibility. It can easily switch ...
RIA kit for the determination of blocking autoantibodies to the acetylcholine receptor (AChR) in serum...
Medicine Products: